| Name | Last modified | Size |
|---|
 | Parent Directory | | |
 | 2015 Langerhans cell sarcoma following marginal zone lymphoma.pdf | 2016-10-11 10:55 | 2179 KB |
| 2015 Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.pdf | 2016-10-12 03:15 | 1852 KB |
| 2016 Vertically transmitted HPV dependent squamous cell.pdf | 2016-10-11 08:02 | 1461 KB |
| 2017 Heterogeneity and frequency of BRAF mutations in primary.pdf | 2017-06-13 09:18 | 4151 KB |
| 2017 Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients.pdf | 2017-06-14 02:00 | 590 KB |
| 2017 “Omic” Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine.pdf | 2017-06-13 08:53 | 783 KB |
| 2018 Capillary electrophoresis as alternative method to detect tumor genetic mutations the model built on the founder BRCA1 c.4964_4982del19 variant.pdf | 2018-06-27 06:33 | 1429 KB |
| 2018 Orthokeratinized odontogenic cysts a Spanish tertiary care centre study based on HPV DNA detection.pdf | 2018-08-20 16:24 | 824 KB |
| 2019 A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants 2019.pdf | 2020-03-18 08:40 | 2479 KB |
| 2019 Automated Workflow for Somatic and Germline Next Generation Sequencing.pdf | 2019-11-15 08:13 | 2579 KB |
| 2019 Coping with formalin banning in pathology under vacuum long-term tissue.pdf | 2020-03-18 08:42 | 2009 KB |
| 2019 Coping withformalin banning inpathology undervacuum long-term tissue .._.pdf | 2019-11-15 07:48 | 1597 KB |
| 2019 IGHV mutational status of nodal marginal zone lymphoma by NGS.pdf | 2020-03-18 08:40 | 881 KB |
| 2019 Infiltrates of M2-Like Tumour-Associated.pdf | 2020-03-06 01:14 | 2566 KB |
| 2019 Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression-2019.pdf | 2020-03-18 08:58 | 1419 KB |
| 2019 Morphological,immunohistochemicalandmolecularfeaturesof inflammatorybowe....pdf | 2019-05-27 01:56 | 4012 KB |
| 2019 Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases.pdf | 2020-03-06 01:06 | 374 KB |
| 2019 Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells.pdf | 2019-11-15 08:41 | 2366 KB |
| 2020 Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer.pdf | 2020-05-21 03:36 | 843 KB |
| 2020 Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of TissuePlasma Discordant Cases.pdf | 2021-01-19 07:28 | 1284 KB |
| 2020 Comprehensive Analysis of PTEN in Primary Cutaneous.pdf | 2020-09-30 02:17 | 1301 KB |
| 2020 Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal.pdf | 2020-06-15 03:14 | 945 KB |
| 2020 Genetic trajectory and immune microenvironment.pdf | 2020-05-21 03:35 | 2127 KB |
| 2020 HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.pdf | 2020-09-25 09:57 | 2245 KB |
| 2020 Infiltrates of M2-Like Tumour-Associated.pdf | 2020-04-14 08:54 | 2566 KB |
| 2020 KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay Concordance with standard biopsy and clinical evaluation.pdf | 2021-01-19 07:22 | 943 KB |
| 2020 MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy.pdf | 2021-01-21 01:34 | 313 KB |
| 2020 POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.pdf | 2020-09-24 03:00 | 1517 KB |
| 2020 Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).pdf | 2021-01-19 07:33 | 2625 KB |
| 2020 Quantitative Assessment of HER2 Gene.pdf | 2021-01-19 07:26 | 254 KB |
| 2020 Salvage lymphadenectomy in recurrent ovarian cancer patients Analysis of clinical outcome and BRCA12 gene mutational status.pdf | 2020-04-14 08:45 | 461 KB |
| 2020 T-cell receptor antibodies expression in benign and malignant cutaneous lymphoid infiltrates in comparison with T-cell receptor gene rearrangement and its diagnostic utility in borderline cases.pdf | 2021-01-19 07:17 | 7481 KB |
| 2021 DIAPH2, PTPRD and HIC1 Gene Polymorphisms and Laryngeal Cancer Risk.pdf | 2021-08-31 06:33 | 331 KB |
| 2021 Droplet digital PCR for large genomic rearrangements detection A promising strategy in tissue BRCA1 testing.pdf | 2022-05-03 08:40 | 4532 KB |
| 2021 MicroRNA Deregulation in Papillary Thyroid Cancer.pdf | 2021-01-19 07:37 | 94 KB |
| 2021 Presence of Chlamydia trachomatis DNA in the amniotic fluid in women with preterm prelabor rupture of membranes.pdf | 2021-08-31 05:30 | 1144 KB |
| 2022 Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches an ImGO pilot study.pdf | 2022-05-03 07:59 | 1176 KB |
| 2022 Role of Homologous Recombination Repair (HRR) Genes in Uterine Leiomyosarcomas A Retrospective Analysis.pdf | 2022-05-03 07:50 | 1580 KB |
| 2022 Spectrum of BRCA12 Mutations in Romanian Breast and Ovarian Cancer Patients.pdf | 2022-05-03 07:53 | 336 KB |
| 2022 Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas.pdf | 2022-09-21 06:46 | 1188 KB |
| 2022 The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer.pdf | 2022-09-21 06:30 | 2148 KB |
| 405 Predictors of Metachronous Risk Polyps After Index Colonoscopy.pdf | 2021-08-31 06:32 | 367 KB |
| desktop.ini | 2020-04-01 06:50 | 0 KB |